Long Island City, New York lab-automation company founded in 2014; builds the OT-2 and Opentrons Flex liquid-handling robots for life-science research labs.
Opentrons Labworks Inc. is a laboratory automation company headquartered in Long Island City, New York, founded in 2014 by Will Canine, Nicholas Wagner, and Chiu Chau, who met through the Genspace community biology lab in New York City. The company builds liquid-handling robots and protocol software for research labs that previously relied on manual pipetting.
The current flagship platform, Opentrons Flex, is an automated liquid handler supporting interchangeable pipettes and an optional robotic gripper for moving labware across the deck; it succeeded the earlier OT-2 pipetting robot, still available for PCR setup, ELISA, sample normalization, and sequencing library preparation. Protocols are written through the open-source Python Protocol API, assembled visually with the no-code Protocol Designer, or generated from natural-language prompts using OpentronsAI, drawing on a shared Protocol Library and Labware Library. Opentrons also sells preconfigured workstations for specific workflows, including nucleic acid extraction, proteomics sample preparation, and PCR setup.
Opentrons has raised more than 200 million dollars in venture funding since an early seed round backed by Khosla Ventures, and its systems are deployed at Carnegie Mellon University, the University of Texas Medical Branch, Boston University's DAMP Lab, and pharmaceutical manufacturer Pfizer.
Primary type & automation activities this supplier delivers:
Open-source liquid handling robot with Python programmability for molecular biology lab automation from $10,000.
Next-generation liquid handling robot for high-throughput complex workflows with 96-channel pipetting and gripper.
Contact Opentrons Labworks Inc.
WEBSITE
https://opentrons.comPHONE
+1 (646) 212-3703HEADQUARTERS
United States
Company Facts
Founded
2014
Primary Role
Manufacturer
Company Size
-
Primary Region
North America
Annual Sales
-
Funding Stage
-
Funding Total
-